| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $10K | -99.7% |
| R&D Expense | $14.2M | -34.0% |
| SG&A Expense | $9.2M | -24.4% |
| Operating Income | -$23.5M | +24.2% |
| Pre-tax Income | -$4.1M | +86.6% |
| Income Tax | $0 | — |
| Net Income | -$4.1M | +86.6% |
| EPS (Basic) | -$0.48 | -37.1% |
| EPS (Diluted) | -$0.48 |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $15.7M | +49.8% |
| Current Assets | $18.4M | +5.2% |
| Total Assets | $22.1M | +3.8% |
| Current Liabilities | $21.6M | +5.5% |
| Total Liabilities | $28.1M | +6.8% |
| Stockholders' Equity | -$6.0M | -19.1% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $5.4M | +113.9% |
| Capital Expenditures | $573K | -9.0% |
| Investing Cash Flow | -$573K | +9.0% |
| Financing Cash Flow | $434K | -97.2% |
| Free Cash Flow | $4.8M | +112.2% |
| -37.1% |